
China Approves First Domestic 9-Valent HPV Vaccine
China’s drug regulator approves the country’s first domestically developed 9-valent HPV vaccine, targeting nine strains to boost protection against cervical cancer.
My Global News: Voices of a New Era
π Stay Ahead, Stay Global π
China’s drug regulator approves the country’s first domestically developed 9-valent HPV vaccine, targeting nine strains to boost protection against cervical cancer.
The Chinese mainland greenlights Cecolin 9, its first domestically developed nine-valent HPV vaccine, promising over 98% protection and an easier two-dose schedule for teens.
Jing’an County rolls out free HPV vaccines for schoolgirls as part of national effort to eliminate cervical cancer, backed by health experts and policymakers.